Pregabalin
NDC 69986-014
Product Information
Pregabalin is a ANDA-approved product labeled by Sinotherapeutics Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a gray product. This product entry covers the primary NDC 69986-014 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
L1 Code Structure Chart
Product Details
What is NDC 69986-014?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- PREGABALIN (UNII: 55JG375S6M)
- PREGABALIN (UNII: 55JG375S6M) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- KOLLIDON SR (UNII: S34RY76LK6)
- POLYETHYLENE OXIDE 2000000 (UNII: 5K3991GVWI)
- CARBOMER HOMOPOLYMER TYPE A (UNII: F68VH75CJC)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- POLYVINYL ALCOHOL (UNII: 532B59J990)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- TALC (UNII: 7SEV7J4R1U)
- POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1988974 - pregabalin 165 MG 24HR Extended Release Oral Tablet
- RxCUI: 1988974 - 24 HR pregabalin 165 MG Extended Release Oral Tablet
- RxCUI: 1988977 - pregabalin 330 MG 24HR Extended Release Oral Tablet
- RxCUI: 1988977 - 24 HR pregabalin 330 MG Extended Release Oral Tablet
- RxCUI: 1988980 - pregabalin 82.5 MG 24HR Extended Release Oral Tablet
* Please review the full disclaimer at the bottom of this page.